117 related articles for article (PubMed ID: 8339388)
21. Anticancer activities of orally administered menogaril against human stomach and breast cancers implanted in nude mice.
Inaba M; Sato S; Yamori T; Tashiro T; Ohnishi Y; Maruo K; Ueyama Y; Tsuruo T
Anticancer Res; 1992; 12(6B):1953-6. PubMed ID: 1295442
[TBL] [Abstract][Full Text] [Related]
22. Activity of menogaril against various malignant lymphoma cell lines and a human lymphoma xenograft in mice.
Yoshida M; Fujioka A; Nakano K; Yuasa C; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(5A):2875-9. PubMed ID: 8917401
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J
Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
[TBL] [Abstract][Full Text] [Related]
24. [TUT-7 phase I clinical study. TUT-7 Study Group].
Taguchi T; Wakui A; Niitani H; Furue H; Majima H; Nakao I; Ota K; Hattori T; Sugimachi K
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1125-33. PubMed ID: 9239166
[TBL] [Abstract][Full Text] [Related]
25. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment.
Lien EA; Solheim E; Ueland PM
Cancer Res; 1991 Sep; 51(18):4837-44. PubMed ID: 1893376
[TBL] [Abstract][Full Text] [Related]
26. Human tissue distribution of platinum after cis-diamminedichloroplatinum.
Stewart DJ; Benjamin RS; Luna M; Feun L; Caprioli R; Seifert W; Loo TL
Cancer Chemother Pharmacol; 1982 Dec; 10(1):51-4. PubMed ID: 6891626
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma. An ECOG randomized phase II study of beta-interferon and menogaril.
Falkson G; Lipsitz S; Borden E; Simson I; Haller D
Am J Clin Oncol; 1995 Aug; 18(4):287-92. PubMed ID: 7625367
[TBL] [Abstract][Full Text] [Related]
28. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
29. [Menogaril (TUT-7) late phase II study for malignant lymphoma, adult T-cell leukemia and lymphoma (ATLL)].
Taguchi T; Ohta K; Hotta T; Shirakawa S; Masaoka T; Kimura I
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1263-71. PubMed ID: 9279345
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetic studies of menogaril (TUT-7) with rats].
Ohashi K; Hara H; Takahashi F; Aso R; Akimoto T; Nakama K
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1825-9. PubMed ID: 1387773
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
[TBL] [Abstract][Full Text] [Related]
32. Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic.
Dorr FA; Von Hoff DD; Kuhn JG; Schwartz R; Kisner DL
Cancer Res; 1986 May; 46(5):2562-5. PubMed ID: 2938729
[TBL] [Abstract][Full Text] [Related]
33. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
[TBL] [Abstract][Full Text] [Related]
34. Human central nervous system and plasma pharmacology of mitoxantrone.
Green RM; Stewart DJ; Hugenholtz H; Richard MT; Thibault M; Montpetit V
J Neurooncol; 1988; 6(1):75-83. PubMed ID: 3397768
[TBL] [Abstract][Full Text] [Related]
35. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
36. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin.
Rohwedder R; Bergan T; Caruso E; Thorsteinsson SB; Della Torre H; Scholl H
Chemotherapy; 1991; 37(4):229-38. PubMed ID: 1790720
[TBL] [Abstract][Full Text] [Related]
37. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group.
Dutcher JP; Leong T; Makary AZ; Bennett J; Frontiera M; Miller H; Wiernik PH
Leukemia; 1995 Oct; 9(10):1638-42. PubMed ID: 7564502
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
Stephens RL; Goodman P; Crawford ED; Spicer CF; Lowe BA; Ahmann FR; Chapman R; Natale RB
Invest New Drugs; 1990; 8 Suppl 1():S69-71. PubMed ID: 2143177
[TBL] [Abstract][Full Text] [Related]
40. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]